Uncoupling of gene expression from copy number presents therapeutic opportunities in aneuploid cancers

Vakul Mohanty1, Fang Wang1, Gordon B Mills2

  • 1Department of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.

Cell Reports. Medicine
|August 2, 2021
PubMed

Insights

Uncoupling of mRNA expression from copy number (UECN) helps cancer cells survive high aneuploidy. This study reveals UECN is common, linked to tumor growth and immune evasion, and offers potential therapeutic targets.

Area of Science:

  • Cancer Biology
  • Genomics
  • Systems Biology

Background:

  • Aneuploidy, an abnormal chromosome number, is common in cancer.
  • Uncoupling of mRNA expression from copy number (UECN) may allow cancer cells to tolerate aneuploidy.

Purpose of the Study:

  • To investigate the prevalence and role of UECN across various cancer types.
  • To identify regulatory mechanisms and potential therapeutic targets for UECN.

Main Methods:

  • Integrative multiomic analysis of The Cancer Genome Atlas (TCGA) dataset (∼5,000 tumors).
  • Development of a systems-biology approach to identify candidate transcription factors (TFs).

Main Results:

  • UECN is a common phenomenon in cancer.
  • UECN correlates with increased oncogenic signaling, proliferation, and immune suppression.
  • Identified 21 putative TF targets, with 42.8% validated by independent sources.

Conclusions:

  • UECN is a significant mechanism in the development of aneuploid tumors.
  • Targeting TFs involved in UECN may offer a therapeutic strategy to reduce tumor fitness.

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.0K
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
5.3K
Epigenetic Regulation01:37

Epigenetic Regulation

Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
3.2K
Epigenetic Regulation01:46

Epigenetic Regulation

Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
31.7K
Nondisjunction01:21

Nondisjunction

Nondisjunction is the failure of homologous chromosomes or sister chromatids to separate correctly and move to the opposite poles of the cells. This produces daughter cells with abnormal chromosome numbers.  Nondisjunction is common during anaphase I or anaphase II of meiosis.  Mutations in synaptonemal complex proteins that attach homologous chromosomes increase the chances of nondisjunction in anaphase I of meiosis I. In contrast, mutations in topoisomerases and condensins that hold...
4.3K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.3K